The European Commission is today releasing €10 million for research on the Zika virus, currently affecting large parts of Latin America.
The most affected country is Brazil, where the World Health Organisation (WHO) has declared that the recent cluster of severe brain malformations in new-borns may be linked to the virus. While the risk of transmission of the Zika virus in the EU is low, there is currently no treatment or vaccine against the virus, and diagnostic tests for infections are not widely available.
